首页|期刊导航|世界科学技术-中医药现代化|基于网络毒理学、分子对接技术及实验验证探讨注射用血栓通致类过敏反应的作用机制

基于网络毒理学、分子对接技术及实验验证探讨注射用血栓通致类过敏反应的作用机制OA

Mechanism of Pseudo-allergic Reactions Induced by Xueshuantong Injection Based on Network Toxicology,Molecular Docking Technology and Experimental Verification

中文摘要英文摘要

目的 运用网络毒理学方法预测注射用血栓通(XSTI)致类过敏反应(PARs)的作用机制,并通过分子对接技术和体内动物实验进行初步验证.方法 通过网络毒理学方法,筛选XSTI活性成分及其作用靶点,构建"成分-靶点-疾病"网络,进行基因本体(GO)功能富集分析和京都基因与基因组百科全书(KEGG)通路富集分析,以初步探寻其潜在作用机制.运用分子对接技术,验证关键活性成分和核心靶点的结合活性.最后开展实验验证,通过动物实验观察XSTI对PARs相关指标的影响,从体内水平验证网络毒理学和分子对接结果.结果 XSTI作用靶点共863个,与PARs交集靶蛋白共187个,其中白细胞介素-6(IL-6)、肿瘤坏死因子(TNF)、肿瘤蛋白53(TP53)、表皮生长因子受体(EGFR)、汇丝氨酸/苏氨酸激酶1(AKT1)和信号传导及转录激活蛋白(STAT3)等为主要作用靶点,主要参与TNF信号通路、非受体酪氨酸激酶(JAK3)及磷脂酰肌醇3-激酶(PI3K)-AKT等信号通路.动物实验验证发现,XSTI低剂量组小鼠症状的类过敏反应为阳性,血液生物标志物水平却未显著升高;XSTI高剂量组小鼠症状依次是类过敏反应阳性、强阳性,免疫球蛋白E(IgE)水平下降显著,血液β-氨基己糖苷酶水平升高显著.取小鼠皮肤对核心靶点进行验证,发现XSTI高剂量组小鼠皮肤组织的TNF和TP53的mRNA的表达均显著高于空白对照组小鼠.结论 本研究揭示了XSTI致PARs的潜在作用机制,为临床安全用药及不良反应防控提供理论依据与实验支撑.

Objective The mechanism of the pseudo-allergic reactions(PARs)induced by Xueshuantong injection(XSTI)was predicted using the method of network toxicology,and was preliminarily verified through molecular docking technology and in vivo animal experiments.Methods Through the method of network toxicology,the active ingredients of XSTI and their action targets were screened.A"component-target-disease"network was constructed,and gene ontology(GO)functional enrichment analysis and Kyoto encyclopedia of genes and genomes(KEGG)pathway enrichment analysis were carried out to preliminarily explore its potential mechanism of action.Molecular docking technology was used to verify the binding activity between the key active ingredients and the core targets.Finally,experimental verification was carried out.The effects of XSTI on the indicators related to PARs were observed through animal experiments,and the results of network toxicology and molecular docking were verified at the in vivo level.Results XSTI was predicted to interact with 863 potential targets,among which 187 overlapping targets were shared with PARs.Key targets including interleukin-6(IL-6),tumor necrosis factor(TNF),tumor protein 53(TP53),epidermal growth factor receptor(EGFR),serine/threonine-protein kinases 1(AKT1),and signal transducer and activator of transcription(STAT3)were identified,primarily associated with the TNF,janus tyrosine kinase(JAK)/STAT3 and phosphatidylinositol 3-kinase(PI3K)-AKT signaling pathway.In vivo experiments demonstrated that animals in the low-dose XSTI group exhibited systemic symptoms classified as allergen-like reaction-positive,though no significant elevation in blood biomarker levels was detected.Conversely,the high-dose XSTI group displayed systemic symptoms ranging from allergen-like reaction-positive to strongly positive,accompanied by a marked reduction in IgE antibody levels and a significant increase in β-hexosaminidase levels in blood.Further validation of core targets in mouse skin tissues revealed that mRNA expression levels of TNF and TP53 in high-dose XSTI group were significantly elevated compared to the blank control group.Conclusion This study elucidates the underlying mechanisms of XSTI-induced PARs,providing a theoretical foundation and experimental evidence to support clinical medication safety and the prevention and control of adverse drug reactions.

李霞;曲木达尔木;张秀盟;王佳怡;万小燕;唐海龙;邵晓妮

成都市双流区第一人民医院/四川大学华西空港医院 成都 610200西南民族大学药学与食品学院 成都 610041成都市双流区第一人民医院/四川大学华西空港医院 成都 610200成都市双流区第一人民医院/四川大学华西空港医院 成都 610200成都市双流区第一人民医院/四川大学华西空港医院 成都 610200成都市双流区第一人民医院/四川大学华西空港医院 成都 610200西南民族大学药学与食品学院 成都 610041

医药卫生

注射用血栓通类过敏反应网络毒理学分子对接技术实验验证

Xueshuantong injectionPseudo-allergic reactionsNetwork toxicologyMolecular docking technologyExperimental verification

《世界科学技术-中医药现代化》 2026 (4)

1217-1233,17

四川省中医药管理局中医药科研专项资助-面上项目科学技术研究专项课题(2024MS600):基于网络药理学实验验证和Logistic回归模型对我院血栓通注射剂的临床不良反应研究,负责人:李霞.

10.11842/wst.20250429003

评论